Costimulation Blockade Increases Risk of Ventricular Rupture in a Preclinical Model of Transmural Myocardial Injury
Florian Sicklinger, Clara Heine, Daniel Finke, Laura M Wienecke, Lorenz H Lehmann, Norbert Frey, Florian Leuschner · 2026
Read Costimulation Blockade Increases Risk of Ventricular Rupture in a Preclinical Model of Transmural Myocardial Injury by Florian Sicklinger, Clara Heine, Daniel Finke, Laura M Wienecke, Lorenz H Lehmann, Norbert Frey, Florian Leuschner (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571914.txt.
Description
Florian Sicklinger and co-authors report in 2026 that a T cell calming drug may raise the risk of a torn heart wall after deep heart harm. The drug, abatacept, is used for grave heart swelling caused by cancer immune drugs. A 67-year-old woman on it for such swelling was found with a sealed tear in her left heart wall, at a spot once inflamed.
The team then tested the drug in mice after heart attacks. Treated mice tore more and died more than untreated mice, the figures show. The drug is known to sway repair cells and scar builders, not just T cells. The work warns that calming the immune reply can slow the scar that holds the wall. More checks on timing and dose are due.
Catalog record
| CREATOR | Florian Sicklinger, Clara Heine, Daniel Finke, Laura M Wienecke, Lorenz H Lehmann, Norbert Frey, Florian Leuschner |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |